Carl Icahn Icahn Carl
Carl Icahn is one of the most famous activist investors in U.S. markets, with decades of campaigns to change corporate strategy, capital allocation, and leadership. Through Icahn-related entities he has taken large stakes in companies he views as undervalued or poorly run. His approach combines financial engineering, board engagement, and public pressure to unlock shareholder value.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$853M |
| 2 |
FirstEnergy
FE
|
+$620M |
| 3 |
Dana Inc
DAN
|
+$185M |
| 4 |
TEN
Tenneco Inc. Class A Voting Common Stock
TEN
|
+$25.2M |
| 5 |
Xerox
XRX
|
+$23.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Herbalife
HLF
|
+$616M |
| 2 |
Occidental Petroleum
OXY
|
+$65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 71.2% |
| 2 | Consumer Staples | 6.4% |
| 3 | Industrials | 5.65% |
| 4 | Consumer Discretionary | 4.75% |
| 5 | Healthcare | 4.54% |
Similar funds
Carl Icahn's Q1 2021 Portfolio in Review
As of Q1 2021, Carl Icahn held 19 positions worth $23.8B, up 19% from $20.1B the previous quarter. Its ten largest holdings account for 91% of the portfolio.
Carl Icahn deployed $1.03B of net new capital in Q1 2021, opening 1 new position and adding to 4 existing holdings. Its largest new stake was FirstEnergy: 18,967,757 shares worth $658M.
By sector, the portfolio is most concentrated in Energy at 71% of assets, down from 75% a quarter earlier, followed by Consumer Staples and Industrials.
On the sell side, the largest reduction was Herbalife, an estimated $616M trimmed.
- Carl Icahn's largest Q1 2021 buy was FirstEnergy: 18,967,757 shares worth $658M.
- Carl Icahn added most to Bausch Health in Q1 2021, an estimated $853M increase.
- Carl Icahn's biggest Q1 2021 reduction was Herbalife, cutting an estimated $616M.
- Carl Icahn's ten largest holdings make up 91% of its $23.8B portfolio in Q1 2021.
- Carl Icahn opened 1 new position and closed 0 in Q1 2021.
- Carl Icahn's portfolio value rose 19% quarter-over-quarter to $23.8B.
Based on Icahn Carl's 13F filing for Q1 2021, filed 14 May 2021.